Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petrou

Showing results (11-20 of 2,091) with videos related to

Pageof 210
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2023
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an updatePanagiotis Petrou
Health Economics|December 18, 2001
Methodological limitations of economic evaluations of antenatal screeningS Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2023
Budget impact analysis of daratumumab for light-chain amyloidosis in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|July 22, 2014
Methodological and applied concerns surrounding age-related weighting within health economic evaluationStavros Petrou
Evidence-Based Mental Health|August 5, 2010
A stepped care programme for depressive or anxiety disorders offers good value for moneyStavros Petrou
Applied Health Economics and Health Policy|April 21, 2015
An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|May 5, 2021
Assessing the pricing and benefits of oncology products: an updatePanagiotis Petrou
Public Health|September 24, 2015
The Ariadne's thread in co-payment, primary health care usage and financial crisis: findings from Cyprus public health care sectorP Petrou
International Journal of Public Health|October 5, 2018
Seeking to introduce a pharmacoeconomics framework in CyprusPanagiotis Petrou
Journal of Medical Economics|June 12, 2023
CAR-T therapy for multiple myeloma in China. Does it make sense financially?Panagiotis Petrou
Pageof 210

Showing results (11-20 of 2,091) with videos related to

Sort By:
Pageof 210
Expert Review of Pharmacoeconomics & Outcomes Research|June 8, 2023
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an updatePanagiotis Petrou
Health Economics|December 18, 2001
Methodological limitations of economic evaluations of antenatal screeningS Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2023
Budget impact analysis of daratumumab for light-chain amyloidosis in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|July 22, 2014
Methodological and applied concerns surrounding age-related weighting within health economic evaluationStavros Petrou
Evidence-Based Mental Health|August 5, 2010
A stepped care programme for depressive or anxiety disorders offers good value for moneyStavros Petrou
Applied Health Economics and Health Policy|April 21, 2015
An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in CyprusPanagiotis Petrou
Expert Review of Pharmacoeconomics & Outcomes Research|May 5, 2021
Assessing the pricing and benefits of oncology products: an updatePanagiotis Petrou
Public Health|September 24, 2015
The Ariadne's thread in co-payment, primary health care usage and financial crisis: findings from Cyprus public health care sectorP Petrou
International Journal of Public Health|October 5, 2018
Seeking to introduce a pharmacoeconomics framework in CyprusPanagiotis Petrou
Journal of Medical Economics|June 12, 2023
CAR-T therapy for multiple myeloma in China. Does it make sense financially?Panagiotis Petrou
Pageof 210